Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Cardiologist recalls role in getting LA police to stop using chokeholds, connects experience with current events

In 1982, LAPD Police Chief Darryl Gates called the cardiologist with an unexpected question. 

Thumbnail

CV societies ‘very concerned’ about proposed coverage changes for MR therapy

The American College of Cardiology, Society of Thoracic Surgeons, American Association for Thoracic Surgery and Society for Cardiovascular Angiography and Interventions all collaborated on the response. 

Thumbnail

Consolidation in cardiology: 3 key findings on practice size in the US

Consolidation has been a major theme for healthcare providers in recent years, with larger practices continuing to thrive compared to their smaller counterparts. But what about cardiology specifically? 

Thumbnail

Risk of major cardiovascular events not affected by enrolling in a high-deductible health plan

Researchers tracked more than 302,000 patients with at least one cardiovascular risk factor.

Thumbnail

Cardiology one of healthcare’s top specialties when it comes to net worth, paying off debt

Nearly half of all cardiologists have a net worth between $1 million and $5 million, according to a new report from Medscape.

Thumbnail

American College of Cardiology ‘disappointed’ by Trump’s decision to exit WHO

“Diseases don't respect geographic and political boundaries," wrote ACC President Athena Poppas, MD, and others. 

Thumbnail

Edwards Lifesciences, Abbott agree to end patent dispute

In a statement announcing the news, Edwards said it “considers this agreement a positive development."

Thumbnail

Novo Nordisk acquires Corvidia Therapeutics for $2.1B with eye on cardiovascular disease

An antibody currently being developed by Corvidia, ziltivekimab, is at the center of the big acquisition.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.